methylprednisolone has been researched along with Experimental Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoover, EA; Olsen, RG; Quackenbush, SL; Rojko, JL | 1 |
| Carpenter, R; Cetkovic-Cvrlje, M; Chen, CL; Chen, H; Lisowski, E; Uckun, FM; Vassilev, A; Waurzyniak, B; Zheng, Y | 1 |
| Beyer, JM; Pedersen, BK | 1 |
| Motycka, K; Soucek, J | 1 |
4 other study(ies) available for methylprednisolone and Experimental Leukemia
| Article | Year |
|---|---|
Reactivation of latent feline leukaemia virus infection.
Topics: Adrenal Cortex Hormones; Animals; Antibody-Dependent Cell Cytotoxicity; Antigens, Viral; Bone Marrow; Cats; Cells, Cultured; Female; Leukemia Virus, Feline; Leukemia, Experimental; Leukocytes; Lymphoma, Non-Hodgkin; Macrophages; Male; Methylprednisolone; Virus Activation | 1982 |
In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase.
Topics: Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Antineoplastic Agents; Area Under Curve; Asparaginase; Biological Availability; Blotting, Western; Body Weight; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia, Experimental; Methylprednisolone; Mice; Mice, Inbred BALB C; Nitriles; Protein-Tyrosine Kinases; Rats; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vincristine | 2002 |
Characterization of the in vitro effects of glucocorticosteroids on NK cell activity.
Topics: Adult; Cell Communication; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Hydrocortisone; Interferons; Killer Cells, Natural; Leukemia, Experimental; Leukemia, Myeloid; Methylprednisolone; T-Lymphocytes, Cytotoxic | 1986 |
The treatment of experimental mouse hemoblastosis IV. Thearapy of leukemia L 14 AKR with drugs of demonstrated or potential cytostatic effects.
Topics: Androsterone; Animals; Antimetabolites; Dactinomycin; Leukemia, Experimental; Methylprednisolone; Mice; Nucleosides; Purines | 1965 |